The surgical technique with duodeno-duodenal enteroanastomosis of pancreas transplants allows for representative endoscopic ultrasound-guided needle biopsies of the donor duodenum and the pancreas graft. We assessed whether histological findings in transplanted donor duodenal biopsies can indicate rejection in the transplanted pancreas. Since September 2012, a duodeno-duodenal enteroanastomosis has been the default technique for pancreas transplantations at our center. In 67 recipients we prospectively examined 113 endoscopic ultrasound-guided procedures with representative biopsies from the duodenum grafts and the pancreas grafts (97 per protocol and 16 on indication). All graft biopsies were evaluated according to established rejection criteria. A total of 22 biopsy-proven pancreas rejections were detected, with 2 matching duodenal biopsies showing rejection. This gives a sensitivity of 9% for detection of a pancreas rejection by duodenal biopsies. The other matching duodenal biopsies were either normal (n = 13) or indeterminate (n = 7). Rejection of the donor duodenum was found in only 6/113 biopsies, with 2 concurrent pancreas rejections. In conclusion, the donor duodenum is not a useful reporter organ for rejection in the pancreas graft.
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In September 2012 we changed the method of exocrine drainage from duodeno-jejunal to duodeno-duodenal enteroanastomosis as the surgical technique for both the PTA and SPK procedures. The rationale for this was easier access for protocol and indication biopsies from the donor duodenum and pancreas by endoscopic ultrasound (EUS) guidance. 10 Here we present our experience with concurrently sampled biopsies from the donor duodenum and the pancreas transplant in order to investigate the potential for the donor duodenal segment to be utilized as a reporter organ for rejection in the pancreas graft.
| METHODS
This is a single center prospective study at the Oslo University Hospital approved by the Regional ethical committee for clinical research. We Pancreas graft biopsies were evaluated according to Banff rejection criteria, 9, 11 and biopsies from the duodenal segment were evaluated for rejection according to Wu et al. 12 The category "indeterminate for rejection" is defined by both Wu and Banff and interprets the biopsies neither diagnostic for rejection nor normal. We have categorized our biopsy findings from both organs in Tables 2 and 3 were treated with plasma exchange in addition to ATG and iv methylprednisolone. Donor duodenum rejection was treated with iv methylprednisolone when no concurrent rejection was found in the pancreas graft.
The hospital records of all included patients were reviewed to make sure all biopsies and complications were registered in this analysis.
| Data collection and statistical analyses
This is a retrospective analysis of prospectively collected data. Data analysis was performed using MS Excel (Microsoft Inc, Redmond, WA) and statistical analyses using SPSS (version 22; IBM, Armonk, NY).
Categorical outcomes were described using frequencies and proportions while continuous variables were described using mean ± standard deviation. Group comparisons were performed by a chi-square test or Fisher exact test when appropriate. P values were reported according to 2-tailed analysis, and P < .05 were considered statistically significant.
| RESULTS
Donor duodenum and pancreas graft tissue were successively sampled in 212 EUS-guided fine-needle biopsy procedures from both SPK and PTA recipients, resulting in 113 paired biopsies representative for rejection evaluation from 67 recipients (53%). Eighteen of the pancreas transplants recipients experienced at least 1 episode of pancreas rejection within the study period. Table 2 describes the results from 113 paired all-cause graft biopsies from pancreas and donor duodenum.
| Paired all-cause biopsies from the whole cohort
In the 22 cases of rejections in the pancreas biopsies (22/113), donor duodenum was normal in 13 samples (Figure 1 , 59%) and indeterminate for rejection in 7 samples (32%) while rejection was found in 2 of the concurrent duodenal biopsies (9%).
Normal finding in donor duodenum was present in 95 samples (95/113). Coexisting rejection of the pancreas was found in 13 of these cases. When donor duodenum was found indeterminate for rejection in 12 cases, rejection in the pancreas was found in 7 of these cases. Rejection in donor duodenum was present in 6 of the 113 samples; 2 of these had concurrent pancreas graft rejections. Three had normal findings and 1 had indeterminate findings in the pancreas grafts.
There were 10 cases of indeterminate and not treated rejection findings in pancreas graft biopsies together with normal duodenal findings. One of these cases later developed a clinically significant pancreas rejection within 1 month while the other 9 cases did not develop rejection during the study period (mean follow-up time: 415 days).
In 73 of the 113 (65%) paired biopsies, the results showed concordant histological findings in the 2 organs (rejection +/+, −/−, or ?/?). When the paired biopsies were translated into the 2 categories "rejection" or "no rejection," 9% sensitivity and 96% specificity could be calculated for the donor duodenal segment to reveal a pancreas graft rejection and concordant findings were present in 79% (89/113) of the cases.
| Paired biopsies sampled when rejection was suspected
Sixteen of the 113 concurrent sampled biopsies were performed when pancreas rejections were clinically suspected. A pancreas graft rejection was verified in 9 of these samples. The concurrent donor duodenal findings were normal in 5 samples and indeterminate for rejection in 4 cases. Rejection was not found in any of the matched duodenal samples.
| Paired biopsies sampled by surveillance protocol
Surveillance protocol biopsies are reported in Table 3 donor duodenum was present in 4 cases and 2 of these appeared with concurrent pancreas graft rejections.
| Complications
No severe complications were observed during or after the EUS procedures. Three patients developed mild procedure-related pancreatitis and 2 of these were hospitalized overnight due to symptoms with moderate abdominal pain, and dynamics of their laboratory values of amylase and C-reactive protein were observed. One patient had no such symptoms, but retrospectively a temporary rise in plasma amylase and C-reactive protein were captured at the outpatient clinic.
| DISCUSSION
To the best of our knowledge, this is the first study to show that donor duodenum biopsies are unreliable predictors of rejection in pancreas grafts with enteric drainage.
We found that the overall sensitivity of a duodenal biopsy to detect a pancreas transplant rejection was as low as 9% and thereby inadequate for clinical use. Our findings suggest caution in using the duodenal segment as a reporter organ. [13] [14] [15] Two thirds of the detected rejection episodes of the donor duodenal cuff were isolated findings with completely normal histology in the pancreas. Nakhleh et al reported results from 25 concurrent pancreas and duodenal biopsies in bladder-drained pancreas recipients in 1995 16 and found independent rejection findings in the 2 organs in 24% (6/25) and completely agreement in 36% (9/25) of the cases.
It appears that duodenal rejections generally occur either as isolated phenomena or, in only a minority of cases, as synchronous rejections in both organs. This observation is in line with what is found in SPK recipients in whom highly discordant findings are reported in concurrent biopsies from the kidney and pancreas graft, respectively. [17] [18] [19] We found that normal duodenal graft biopsies had 96% specificity to suggest absence of rejection in the pancreas graft, but we do not recommend utilizing duodenal biopsies for ruling out rejection in the pancreas graft, since almost 60% (13/22) of our diagnosed pancreas graft rejections occurred together with normal duodenal findings.
These findings are in contrast to what others have suggested 3 and also in contrast to the data presented at the Banff 2015 pancreas session. 9 Pancreas graft rejection is diagnosed based on histological evaluation, 9 but the optimal sampling method for pancreas graft biopsies is 22 We experienced that EUS pancreas graft biopsy sampling re- 
23,24
A shortcoming of the study is that the patient sample is of limited size. However, the substantial discordance between rejection findings in the transplanted duodenum versus the pancreas does not encourage us to continue using the donor duodenum as a reporter organ for pancreas rejection. On the other hand, protocol biopsies of the donor duodenum may be justified to reveal duodenal rejections that would require closer follow-up.
In conclusion, the use of duodenal graft biopsies as a substitute for pancreas biopsies does not appear to be reliable.
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